Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Sphingosine kinase inhibitor
BML-EI406-0010 10 mg 93.00 USD
Do you need bulk/larger quantities?
Selective, non-ATP competitive inhibitor of sphingosine kinase (IC50 = 0.5µM GST-hSK; IC50 = 1.1µM intact JC mouse mammary adenovirus carcinoma cells) showing no inhibition of hERK2, hPI3k and hPKCα at concentrations up to 60µM. Cytotoxic effects have been demonstrated against various tumor cell lines including some overexpressing P-glycoprotein or MRP1 (T24, IC50 = 4.6µM; MCF-7, IC50 = 1.2µM; NCI/ADR, IC50 = 1.3µM, MCRF-7/VP, IC50 = 0.9µM). Induced apoptosis in T24 tumor cells.

Product Details

Alternative Name:4-[[4-(4-Chlorophenyl)-1,3-thiazol-2-yl]amino]phenol
Purity:≥98% (TLC)
Appearance:Off-white solid.
Solubility:Soluble in DMSO (>25mg/ml) or 100% ethanol (>25mg/ml).
Shipping:Blue Ice
Long Term Storage:-20°C
Handling:Protect from light and air.
Regulatory Status:RUO - Research Use Only
BML-EI406 Structure
Please mouse over
BML-EI406 Structure

Product Literature References

Antitumor Activity of Sphingosine Kinase Inhibitors: K.J. French, et al.; J. Pharmacol. Exp. Ther. 318, 596 (2006), Abstract; Full Text
Discovery and Evaluation of Inhibitors of Human Sphingosine Kinase: K.J. French, et al.; Cancer Res. 63, 5962 (2003), Abstract; Full Text

Related Literature

Download as PDF

Product Flyers
Exclusive Sphingosine Kinase 1 Inhibitor
Exclusive Sphingosine Kinase 1 Inhibitor
Download as PDF

All new literature pieces